The use of resveratrol in the fight against Cancer in women: a review
DOI:
https://doi.org/10.34119/bjhrv7n4-391Keywords:
antioxidant effects, nutraceuticals, MCF-7 Cells, PCOS, Cancer riskAbstract
Cancer continues to be a major global health challenge, especially among women. Recent scientific studies have focused on resveratrol (RSV), a natural polyphenol found in various foods, as a potential supplementary therapy for cancer. This review assesses the existing evidence on resveratrol's effects on cancer cells, examining its mechanisms, potential benefits, and clinical implications. Research involved analyzing articles sourced from PUBMED with keywords: "(resveratrol) AND (cancer) AND (women)" (197 articles), "(resveratrol) AND (ovarian cancer)" (149 articles), and "(resveratrol) AND (endometrial cancer)" (21 articles). The selection was based on the specificity of results concerning resveratrol’s role in combating women’s cancer, with the most recent articles chosen in cases of redundancy. RSV has demonstrated capabilities to inhibit cancer cell viability and proliferation, including in breast cancer. It influences cell signaling, enhancing apoptosis and reducing tumor growth, and regulates cyclins and kinases to arrest the cell cycle, curbing uncontrolled cell division. RSV’s anti-inflammatory properties potentially suppress tumor progression, and its antioxidant activity activates enzymes to shield cells from oxidative harm, lowering cancer risks. Despite RSV’s promising potential, more research is needed to determine the ideal dosages, safety, and long-term impacts. Maintaining a diet rich in fruits, vegetables, and RSV-containing foods is vital for cancer prevention. RSV supplementation emerges as a promising support in combating cancer.
References
AFROZ, Sabrina et al. Clinical and Preclinical Studies of Inflammatory Cytokines Impact on Endometrial Versus Ovarian Cancer with Obesity: A Comprehensive Literature Review. Gynecology & Reproductive Health, [s. l.], v. 7, n. 1, 2023.
ÁVILA-GÁLVEZ, María Ángeles et al. Dietary Phenolics against Breast Cancer. A Critical Evidence-Based Review and Future Perspectives. International Journal of Molecular Sciences, [s. l.], v. 21, n. 16, p. 5718, 2020.
CAO, Wei et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chinese Medical Journal, [s. l.], v. 134, n. 7, p. 783–791, 2021.
CAVALIERI, Ercole. Etiology and prevention of prevalent types of cancer. Journal of Rare Diseases Research & Treatment, [s. l.], v. 2, n. 3, p. 22–29, 2017.
CHATTERJEE, Kaushiki et al. Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis. Frontiers in Oncology, [s. l.], v. 9, 2019.
CHATTERJEE, Kaushiki et al. Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells. Nutrients, [s. l.], v. 10, n. 2, p. 243, 2018.
CHEN, Jing et al. Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment. Neoplasma, [s. l.], v. 69, n. 05, p. 1129–1137, 2022.
DI CREDICO, Andrea et al. Resveratrol Enhances the Cytotoxic Activity of Lymphocytes from Menopausal Women. Antioxidants, [s. l.], v. 10, n. 12, p. 1914, 2021.
DULL, Ana-Maria et al. Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways. Molecules, [s. l.], v. 24, n. 4, p. 667, 2019.
FADLALMOLA, Hammad Ali et al. Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Pan African Medical Journal, [s. l.], v. 44, 2023.
FARGHADANI, Reyhaneh; NAIDU, Rakesh. The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC). Biomedicine & Pharmacotherapy, [s. l.], v. 165, p. 115170, 2023.
FERRARESI, Alessandra et al. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells, [s. l.], v. 10, n. 11, p. 3213, 2021.
FUKUDA, Tomohiko et al. Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells. Oncology Letters, [s. l.], v. 12, n. 4, p. 2560–2566, 2016.
GAO, Yifeng; TOLLEFSBOL, Trygve O. Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic–Mediating Machinery. International Journal of Molecular Sciences, [s. l.], v. 19, n. 8, p. 2204, 2018.
GOŁĄBEK-GRENDA, Agata et al. Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways. Scientific Reports, [s. l.], v. 13, n. 1, p. 11468, 2023.
GONZÁLEZ-BOSCH, Carmen; ZUNSZAIN, Patricia A.; MANN, Giovanni E. Control of Redox Homeostasis by Short-Chain Fatty Acids: Implications for the Prevention and Treatment of Breast Cancer. Pathogens, [s. l.], v. 12, n. 3, p. 486, 2023.
GUPTA, Subash Chandra et al. Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases. Frontiers in Immunology, [s. l.], v. 9, 2018.
HASSAN, Sehresh et al. Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial. Endocrine, [s. l.], v. 79, n. 1, p. 208–220, 2022.
IERVOLINO, Matteo et al. Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review. Nutrients, [s. l.], v. 13, n. 5, p. 1677, 2021.
JERUSALEM, Guy; LANCELLOTTI, Patrizio; KIM, Sung-Bae. HER2+ breast cancer treatment and cardiotoxicity: monitoring and management. Breast Cancer Research and Treatment, [s. l.], v. 177, n. 2, p. 237–250, 2019.
JIN, Xiaoxia et al. Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer. Cancer Medicine, [s. l.], v. 8, n. 3, p. 1246–1257, 2019.
KARIMI, Arash et al. The therapeutic effects and mechanisms of action of resveratrol on polycystic ovary syndrome: A comprehensive systematic review of clinical, animal and in vitro studies. Clinical and Experimental Pharmacology and Physiology, [s. l.], v. 49, n. 9, p. 935–949, 2022.
KIM, Nayun et al. Stimulatory Anticancer Effect of Resveratrol Mediated by G Protein-Coupled Estrogen Receptor in Colorectal Cancer. Biomolecules & Therapeutics, [s. l.], v. 31, n. 6, p. 655–660, 2023.
KOTTA, Sabna et al. Thermosensitive Hydrogels Loaded with Resveratrol Nanoemulsion: Formulation Optimization by Central Composite Design and Evaluation in MCF-7 Human Breast Cancer Cell Lines. Gels, [s. l.], v. 8, n. 7, p. 450, 2022.
LARIK, Muhammad Omar et al. Effects of resveratrol on polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials. Endocrine, [s. l.], v. 83, n. 1, p. 51–59, 2023.
LAURINDO, Lucas Fornari et al. Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Metabolites, [s. l.], v. 13, n. 1, p. 96, 2023.
LEE, Yoojin; SHIN, Heewook; KIM, Jongsun. In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation. Journal of Innate Immunity, [s. l.], v. 13, n. 2, p. 94–106, 2021.
LIANG, Ying et al. Resveratrol improves ovarian state by inhibiting apoptosis of granulosa cells. Gynecological Endocrinology, [s. l.], v. 39, n. 1, 2023.
LIMA, Milena Procópio de; CARVALHO, Maria das Graças Freitas de. A influência dos antioxidantes na longevidade. Brazilian Journal of Health Review, [s. l.], v. 7, n. 3, p. e69487, 2024.
MATTIUZZI, Camilla; LIPPI, Giuseppe. Current Cancer Epidemiology. Journal of Epidemiology and Global Health, [s. l.], v. 9, n. 4, p. 217, 2019.
MONTALESI, Emiliano et al. Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International Journal of Molecular Sciences, [s. l.], v. 24, n. 3, p. 2148, 2023.
MUHANMODE, Yalikun et al. Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway. Human & Experimental Toxicology, [s. l.], v. 41, p. 096032712210959, 2022.
O’BRIEN, Kylie et al. Integrative Approaches to the Treatment of Cancer. Cancers, [s. l.], v. 14, n. 23, p. 5933, 2022.
PORTELA, Roberta Santos et al. O câncer de mama e o seu impacto psicossocial e sexual em mulheres: uma revisão bibliográfica da literatura / Breast cancer and its psychosocial and sexual impact on women: a literature literature review. Brazilian Journal of Health Review, [s. l.], v. 4, n. 6, p. 28005–28015, 2021.
RAJ, Madhwa H.G. et al. Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells. Gynecologic Oncology, [s. l.], v. 110, n. 3, p. 432–438, 2008.
SALLA, Mohamed et al. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation. International Journal of Molecular Sciences, [s. l.], v. 24, n. 6, p. 5967, 2023.
SALLA, Mohamed et al. Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs. Molecules, [s. l.], v. 25, n. 17, p. 3849, 2020.
SCHMIDT, Betina et al. Resveratrol, Curcumin and Piperine Alter Human Glyoxalase 1 in MCF-7 Breast Cancer Cells. International Journal of Molecular Sciences, [s. l.], v. 21, n. 15, p. 5244, 2020.
SEXTON, Émilie et al. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Molecular Cancer, [s. l.], v. 5, n. 1, p. 45, 2006.
SHETTY, Chaitra et al. Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association. Cureus, [s. l.], 2023.
SINGLA, Rajeev K. et al. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies. Critical Reviews in Food Science and Nutrition, [s. l.], v. 63, n. 33, p. 11880–11924, 2023.
SINHA, Dona et al. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. Seminars in Cancer Biology, [s. l.], v. 40–41, p. 209–232, 2016.
SUZUKI, Takuji et al. Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory Activity against Metalloproteinases. Molecules, [s. l.], v. 28, n. 14, p. 5426, 2023.
VAN DUURSEN, Majorie B. M. Modulation of estrogen synthesis and metabolism by phytoestrogens in vitro and the implications for women’s health. Toxicology Research, [s. l.], v. 6, n. 6, p. 772–794, 2017.
VERVANDIER-FASSEUR, Dominique; LATRUFFE, Norbert. The Potential Use of Resveratrol for Cancer Prevention. Molecules, [s. l.], v. 24, n. 24, p. 4506, 2019.
XU, Xue-Ling et al. Resveratrol Targets a Variety of Oncogenic and Oncosuppressive Signaling for Ovarian Cancer Prevention and Treatment. Antioxidants, [s. l.], v. 10, n. 11, p. 1718, 2021.
YOUNAS, Muhammad et al. Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives. RSC Advances, [s. l.], v. 8, n. 52, p. 29714–29744, 2018.
ZHONG, Zixing; GUO, Xin; ZHENG, Yanmei. Network Pharmacology-Based and Molecular Docking Analysis of Resveratrol’s Pharmacological Effects on Type I Endometrial Cancer. Anti-Cancer Agents in Medicinal Chemistry, [s. l.], v. 22, n. 10, p. 1933–1944, 2022.
